Millennium Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,000
Closed -$277K 7424
2021
Q2
$277K Hold
2,000
﹤0.01% 5793
2021
Q1
$418K Buy
+2,000
New +$401K ﹤0.01% 4974

Millennium Management's HARP Position: Q1 2024 in Review

Millennium Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 25,465 shares — an estimated $290K sold.

Millennium Management first reported a position in HARP in Q1 2019 and held it in 18 quarters. The position peaked at $4.76M in Q3 2021. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

  • Millennium Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Millennium Management sold 25,465 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $290K.
  • Millennium Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 18 quarters.
  • Millennium Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $4.76M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.